ResearcherYamagata UniversityActive in the last 2 years
Hiroyuki Takeda
Matched on ORCID iD 0000-0002-2847-7105; OpenAlex author ID A5001489861. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 4
- Diagnostic performance of droplet digital PCR for KRAS mutation analysis in pancreatic cancer cytology specimens. Co-author DOI 10.1007/s00535-026-02447-9↗
- Quality-of-life survey of pancreatic cancer patients: a comparison between general public and physicians. Co-author DOI 10.3389/frhs.2024.1275496↗
- Rho-Associated Protein Kinase (ROCK) Inhibitors Inhibit Survivin Expression and Sensitize Pancreatic Cancer Stem Cells to Gemcitabine. Co-author DOI 10.21873/anticanres.11227↗
- JNK suppression of chemotherapeutic agents-induced ROS confers chemoresistance on pancreatic cancer stem cells. Co-author DOI 10.18632/oncotarget.2693↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kumiko Umemoto · 2 shared papers, 2024–2026 · strength 0.42
- Yu Sunakawa · 2 shared papers, 2024–2026 · strength 0.42
- Takashi Yoshioka · 3 shared papers, 2015–2024 · strength 0.30
- Paper Quality-of-life survey of pancreatic cancer patients: a comparison between general public and physicians. DOI 10.3389/frhs.2024.1275496↗
- Paper Rho-Associated Protein Kinase (ROCK) Inhibitors Inhibit Survivin Expression and Sensitize Pancreatic Cancer Stem Cells … DOI 10.21873/anticanres.11227↗
- Paper JNK suppression of chemotherapeutic agents-induced ROS confers chemoresistance on pancreatic cancer stem cells. DOI 10.18632/oncotarget.2693↗
- Kazunari Nakahara · 1 shared paper, 2026 · strength 0.23
- Yosuke Igarashi · 1 shared paper, 2026 · strength 0.23
- Tomoko Norose · 1 shared paper, 2026 · strength 0.23
- Junki Koike · 1 shared paper, 2026 · strength 0.23
- Yuriko Sasahara · 1 shared paper, 2024 · strength 0.19
- Yuki Takumoto · 1 shared paper, 2024 · strength 0.19
- Hiroto Narimatsu · 1 shared paper, 2024 · strength 0.19
- Manabu Akazawa · 1 shared paper, 2024 · strength 0.19
- Makoto Ueno · 1 shared paper, 2024 · strength 0.19
- Chifumi Kitanaka · 2 shared papers, 2015–2016 · strength 0.11
- Paper Rho-Associated Protein Kinase (ROCK) Inhibitors Inhibit Survivin Expression and Sensitize Pancreatic Cancer Stem Cells … DOI 10.21873/anticanres.11227↗
- Paper JNK suppression of chemotherapeutic agents-induced ROS confers chemoresistance on pancreatic cancer stem cells. DOI 10.18632/oncotarget.2693↗
- Shuhei Suzuki · 2 shared papers, 2015–2016 · strength 0.11
- Paper Rho-Associated Protein Kinase (ROCK) Inhibitors Inhibit Survivin Expression and Sensitize Pancreatic Cancer Stem Cells … DOI 10.21873/anticanres.11227↗
- Paper JNK suppression of chemotherapeutic agents-induced ROS confers chemoresistance on pancreatic cancer stem cells. DOI 10.18632/oncotarget.2693↗
- Tomomi Sanomachi · 1 shared paper, 2016 · strength 0.06
- Atsushi Satō · 1 shared paper, 2015 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.